Technique allows the doctor to find out how well patients respond to treatment given.It also reflects an increase in determining the diagnostic tests that are currently still in the form of invasive and can only be done once.All this to determine the diagnosis of lung cancer through a procedure called bronchoscopy, which took tissue samples from the airways using a needle.Lung cancer is one type of cancer is difficult to cure. Now a simple new technique could help improve diagnosis and treatment options for patients with lung cancer.This technique involves the calculation of the number of tumor cells in blood samples taken before and after patients underwent chemotherapy.
In a report recently published Journal of Clinical Oncology, researchers explain how studying the number of circulating tumor cells (circulating tumor cells / CTCs) in 101 patients with lung cancer before and after performing one cycle of chemotherapy.The research team believes that by counting CTCs then the doctor can monitor how well patients respond to chemotherapy are done. If the known number of cells increases, will be given different treatment that might respond better.”Our research shows a new way to monitor how the response of treatment and determining how aggressive it is.